The Wolbachia Genome of Brugia malayi: Endosymbiont Evolution within a Human Pathogenic Nematode

**Background:** Filarial nematode infections, including lymphatic filariasis (caused by Wuchereria bancrofti and Brugia malayi) and onchocerciasis (caused by Onchocerca volvulus), affect over 150 million people worldwide, with 1 billion at risk. These parasites harbor intracellular Wolbachia bacteria, which are required for worm fertility and survival. Antibiotic treatments targeting Wolbachia (e.g., doxycycline) have shown efficacy in depleting the bacteria and disrupting embryogenesis in human trials. The genome of Wolbachia from B. malayi (wBm) was sequenced to understand the molecular basis of this mutualistic relationship and to identify new drug targets.

**Methods:** DNA was extracted from B. malayi microfilariae, and bacterial artificial chromosome (BAC) libraries were constructed to obtain purified Wolbachia DNA. A minimum tiling path of 21 BACs was subcloned into plasmid vectors for sequencing. The genome was sequenced to an average coverage of 10.7× using dye terminator chemistry on MegaBace 1000 sequencers. Assembly was performed with PHRED–PHRAP–CONSED, and gaps were closed by primer walking. Gene identification used Integrated Genomics ERGO software, COGNITOR for COG assignments, BLASTP, and GeneMarkS. Metabolic pathways were reconstructed using KEGG and ERGO databases. Comparative analyses were performed with Wolbachia from Drosophila melanogaster (wMel) and Rickettsia species.

**Key Results:** The wBm genome is a single circular chromosome of 1,080,084 base pairs with 34% G+C content. It contains 806 predicted protein-coding genes, 34 tRNAs, and single copies of 16S, 23S, and 5S rRNA genes that do not form an operon. Compared to wMel, wBm has a smaller genome (1.08 Mb vs. 1.27 Mb) and fewer repeats (5.4% vs. >14% repetitive DNA), with no prophages detected. Both Wolbachia species have lost many genes for lipopolysaccharide (LPS) biosynthesis, including all genes for lipid A synthesis, suggesting their cell walls lack typical Gram-negative LPS. wBm retains complete pathways for de novo biosynthesis of purines, pyrimidines, riboflavin, flavin adenine dinucleotide (FAD), heme, and glutathione, but can synthesize only one amino acid (meso-diaminopimelate). The genome lacks genes for glycolysis (e.g., 6-phosphofructokinase, pyruvate kinase) but contains gluconeogenic enzymes. wBm encodes a WASP family protein (Wbm0076) potentially involved in actin-based motility, and five ankyrin-repeat-containing proteins. Comparative analysis shows extensive genome shuffling between wBm and wMel, with no colinearity of gene order.

**Clinical Implications:** The wBm genome reveals that Wolbachia provides essential metabolites (riboflavin, FAD, heme, nucleotides) to its nematode host, which cannot synthesize these compounds. This mutualistic dependency explains why antibiotic depletion of Wolbachia leads to worm sterility and death. The absence of LPS biosynthesis genes suggests that Wolbachia's inflammatory effects in filarial disease may be mediated by peptidoglycan derivatives or surface proteins rather than classical endotoxin. The genome identifies multiple potential drug targets, including pathways for heme, riboflavin, and nucleotide biosynthesis, which are absent in the host nematode. These findings support the development of anti-Wolbachia therapies as a novel strategy for treating lymphatic filariasis and onchocerciasis, potentially overcoming limitations of current drugs that primarily target microfilariae and require repeated dosing.